0001758725-24-000002.txt : 20240220
0001758725-24-000002.hdr.sgml : 20240220
20240220104549
ACCESSION NUMBER: 0001758725-24-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
EFFECTIVENESS DATE: 20240220
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001758725
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-505273
FILM NUMBER: 24651389
BUSINESS ADDRESS:
STREET 1: 201 KING OF PRUSSIA RD., STE. 650
CITY: RADNOR
STATE: PA
ZIP: 19087
BUSINESS PHONE: 2675607402
MAIL ADDRESS:
STREET 1: 201 KING OF PRUSSIA RD., STE. 650
CITY: RADNOR
STATE: PA
ZIP: 19087
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001758725
Nia Therapeutics, Inc.
201 KING OF PRUSSIA RD., STE. 650
RADNOR
PA
PENNSYLVANIA
19087
2675607402
DELAWARE
Nia Therapeutics, LLC
None
Corporation
true
Daniel
Rizzuto
201 King of Prussia Road, Suite 650
Radnor
PA
PENNSYLVANIA
19087
Executive Officer
Director
Daniil
Utin
201 King of Prussia Road, Suite 650
Radnor
PA
PENNSYLVANIA
19087
Executive Officer
Larry
Greenberg
201 King of Prussia Road, Suite 650
Radnor
PA
PENNSYLVANIA
19087
Director
Jonathan
Wachter
201 King of Prussia Road, Suite 650
Radnor
PA
PENNSYLVANIA
19087
Director
Other Health Care
Decline to Disclose
- 06b
true
0001758725-24-000001
true
false
true
false
0
1
0
1
The 2/14/2024 New Notice filing was submitted in error, it should of been an amendment to a previously filed form-d. This amendment is to cancel the 2/14/2024 filing and an amendmendment filing is being made to the 2023 filed form-D as previously intended
false
0
0
0
0
true
false
Nia Therapeutics, Inc.
Daniel Rizzuto
Daniel Rizzuto
CEO
2024-02-20